Back to search
FDAFDA · Food and drugs·Recall number D1292-2014

METHYLDOPA Tablets USP, 500 mg, 100 count bottle, Rx only, Manufactured In INDIA By: EMCURE PHARMACEUTICALS LTD harmaceuticals Ltd., Hinjwadi, Pune, India, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-2932-01

Published May 21, 2014 · Recall initiated: March 24, 2014

Summary

FDA records drug Class II recall D1292-2014, published May 21, 2014 and initiated March 24, 2014. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 22820 bottles; Lot: TE36053A,TE36063A, Exp. 06/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teva Pharmaceuticals USA
Distributor
Nationwide
Lot
TE36053A,TE36063A, Exp. 06/16
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was METHYLDOPA Tablets USP, 500 mg, 100 count bottle, Rx only, Manufactured In INDIA By: EMCURE PHARMACEUTICALS LTD harmaceuticals Ltd., Hinjwadi, Pune, India, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-2932-01 recalled?

Yes. FDA published recall D1292-2014 on May 21, 2014. Reported hazard: CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements

What should I do if I have this product?

Voluntary: Firm initiated · Letter